a study to compare two treatment options for melasma.
Phase 4
- Conditions
- Health Condition 1: null- facial melasma
- Registration Number
- CTRI/2018/05/014062
- Lead Sponsor
- Pawan Gupta
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All consenting male and female patients diagnosed clinically with melasma
Exclusion Criteria
a)Pregnancy, lactation and females taking HRT/OCPâ??s
b)Any severe chronic medical illness,
c)Bleeding disorders or concomitant use of anticoagulants
d)Any medical treatment for melasma within 1 month of entry,
e)Hypersensitivity to TXA
f)Abnormal bleeding time, clotting time or platelet count
g)Refusal to allow photographs and Failure to finish the whole period of study would be excluded from the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method improvement in modified melasma area and severity index (mMASI).Timepoint: 4 weeks, 8 weeks and 12 weeks
- Secondary Outcome Measures
Name Time Method physicianâ??s global assessment and patient global assessment scales, and safety assessmentTimepoint: 12 weeks